Peter J. Crack

Peter Crack is head of the neuropharmacology research group in the Department of Biochemistry and Pharmacology at the University of Melbourne, Melbourne, Australia.

His group's research interests focuses on the mechanisms of cell death seen in neural injury and the effect of oxidative stress and neuroinflammation in contributing to neural cell death, in both acute and chronic neuropathologies.

His work has recently focused on the role that the type-I interferons play in the regulation of neuroinflammation in traumatic brain injury and Alzheimer's disease.

Peter received his PhD in pharmacology in 1996 at the Baker Medical Research Institute, Monash University. He pursued a postdoctoral fellowship at Mount Sinai Medical School, Fishberg Centre for Neuroscience, New York (1995-1999).

He returned to Australia in 1999 to join the Monash Institute of Medical Research where he became a Senior Scientist in 2002. Peter took up a lectureship in the Department of Pharmacology and Therapeutics (2006), was promoted to Senior Lecturer (2008) and Associate Professor (2013). He was awarded an ARC Future Fellowship from the years 2012 to 2015 and was promoted to the level of Professor in 2019.